Please download the dossier by clicking on the dossier button x
×

Hepatitis B Antiviral Agents

  • US 20160332996A1
  • Filed: 05/12/2016
  • Published: 11/17/2016
  • Est. Priority Date: 05/13/2015
  • Status: Active Grant
First Claim
Patent Images

1. A compound represented by Formula (I):


  • X-A-Y—

    Z-L-R1



    (I),or a pharmaceutically acceptable salt thereof, wherein;

    X is an optionally substituted aryl or optionally substituted heteroaryl;

    A is absent, —

    NHCO—

    or optionally substituted azolyl;

    Y is an optionally substituted arylamino or optionally substituted heteroarylamino;

    wherein the said amino group is directly connected to A, X when A is absent or Z;

    Z is —

    S(O)2

    , —

    C(O)—

    , or —

    C(O)C(O)—

    ;

    L is —

    NR2

    , O or —

    CR1R2

    ; and

    R1 and R2 at each occurrence are each independently selected from the group of consisting of hydrogen, optionally substituted —

    C1-C8 alkyl, optionally substituted —

    C2-C8 alkenyl, optionally substituted —

    C2-C8 alkynyl, optionally substituted —

    C3-C8 cycloalkyl, optionally substituted 3- to 8-membered heterocyclic, optionally substituted aryl and optionally substituted heteroaryl; and

    alternatively, R1 and R2 are taken together with the atom to which they are attached to form an optionally substituted C3-C8 cycloalkyl or an optionally substituted 3- to 8-membered heterocyclic.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×